IP Library Granted Patent US 8,318,420
Granted Patent B2
US 8,318,420 · App. 12/834,116 · Granted Nov 27, 2012

Heated assays for influenza

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,420
App. No.
12/834,116
Granted
Nov 27, 2012
Kind
B2
Abstract

Methods of increasing specific binding, decreasing non-specific binding, and reducing false-positive interaction in solid phase assays for influenza are disclosed. In the methods, the solid phase apparatus (lateral flow solid phase apparatus or capillary flow solid phase apparatus) is subjected to elevated heat subsequent to application of a test sample to the solid phase apparatus.

Claims (16)

1. A method for decreasing non-specific binding of influenza detection particles on a solid phase apparatus in an assay for influenza, the method comprising subjecting a solid phase apparatus having influenza detection particles applied thereon to an elevated temperature subsequent to application of a test sample to the solid phase apparatus, whereby the non-specific binding of the influenza detection particles on the solid phase apparatus is decreased.

2. The method of claim 1 , wherein the influenza is selected from the group consisting of: influenza A and influenza B.

3. The method of claim 1 , wherein the solid phase apparatus comprises an application point and at least one sample capture zone having at least one sample capture reagent immobilized thereon.

4. The method of claim 3 , wherein the influenza detection particles are applied at the application point and, upon subsequent application of the test sample, are moved by capillary action through the solid phase apparatus to and through the sample capture zone, and wherein influenza detection particles may bind to a sample capture reagent.

5. The method of claim 3 , wherein the test sample comprises the influenza detection particles, and wherein the application of the test sample to the solid phase apparatus applies the influenza detection particles to the solid phase apparatus and results in movement of the influenza detection particles through the solid phase apparatus by capillary action to and through the sample capture zone, and wherein influenza detection particles may bind to a sample capture reagent.

6. The method of claim 3 , wherein the solid phase apparatus is a lateral flow solid phase apparatus.

7. The method of claim 3 , wherein the solid phase apparatus is a capillary flow solid phase apparatus.

8. The method of claim 1 , wherein the elevated temperature is about 5 to 20 degrees Celsius above ambient temperature.

9. A method for increasing specific binding of influenza detection particles on a solid phase apparatus in an assay for influenza, the method comprising subjecting a solid phase apparatus having influenza detection particles applied thereon to an elevated temperature subsequent to application of a test sample to the solid phase apparatus, whereby the specific binding of influenza detection particles on the solid phase apparatus is increased.

10. The method of claim 9 , wherein the influenza is selected from the group consisting of: influenza A and influenza B.

11. The method of claim 9 , wherein the solid phase apparatus comprises an application point and at least one sample capture zone having at least one sample capture reagent immobilized thereon.

12. The method of claim 11 , wherein the influenza detection particles are applied at the application point and, upon subsequent application of the test sample, are moved by capillary action through the solid phase apparatus to and through the sample capture zone, and wherein influenza detection particles may bind to a sample capture reagent.

13. The method of claim 11 , wherein the test sample comprises the influenza detection particles, and wherein the application of the test sample to the solid phase apparatus applies the influenza detection particles to the solid phase apparatus and results in movement of the influenza detection particles through the solid phase apparatus by capillary action to and through the sample capture zone, and wherein influenza detection particles may bind to a sample capture reagent.

14. The method of claim 11 , wherein the solid phase apparatus is a lateral flow solid phase apparatus.

15. The method of claim 11 , wherein the solid phase apparatus is a capillary flow solid phase apparatus.

16. The method of claim 9 , wherein the elevated temperature is about 5 to 20 degrees Celsius above ambient temperature.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 16, 2012
From: ORBMED ADVISORS LLC
To: RESPONSE BIOMEDICAL CORP.
Reel/Frame 028051/0730 →
SECURITY AGREEMENT Recorded Nov 23, 2011
From: RESPONSE BIOMEDICAL CORP.
To: ORBIMED ADVISORS LLC
Reel/Frame 027281/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2010
From: FONG, WHALLEY K.; HARRIS, PAUL C.
To: RESPONSE BIOMEDICAL CORPORATION
Reel/Frame 025472/0076 →